Cardiogenic Shock: Clinical Trials

3 trials for Cardiogenic Shock, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 not yet recruiting, 1 recruiting. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Active not recruiting 1, Not yet recruiting 1, Recruiting 1
Phase 21Active not recruiting 1

Follow Cardiogenic Shock: new trials by email Literature Review of Cardiogenic Shock trials Research Report on Cardiogenic Shock

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of FAP iCDC in Acute Myocardial Infarction With Cardiogenic Shock
FAP allogeneic immunosuppressive CAR-DC - Cardiogenic Shock, Cardiogenic Shock Post Myocardial Infarction
Phase 1Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine182026-01-202026-02-02
A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C
Istaroxime, Placebo - Cardiogenic Shock
Phase 1 / Phase 2Active not recruitingWindtree Therapeutics202024-06-012025-08-20
Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO
Packed Red Blood Cells (PRBCs) - Cardiogenic Shock, Extracorporeal Membrane Oxygenation
Phase 1RecruitingUniversity Hospital, Lille2362023-09-182026-09-17

Narrower conditions

Shock, Cardiogenic (3)  ·  Anemia (1)  ·  ST Elevation Myocardial Infarction (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Infarction (3)  ·  Ischemia (3)  ·  Myocardial Infarction (3)  ·  Myocardial Ischemia (3)  ·  Necrosis (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Shock (3)  ·  Vascular Diseases (3)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)

Interventions

Istaroxime (1)  ·  Lactic Acid (1)

Sponsors

Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  University Hospital, Lille (1)  ·  Windtree Therapeutics (1)

Countries

Argentina (1)  ·  China (1)  ·  France (1)  ·  Israel (1)  ·  Italy (1)  ·  Poland (1)  ·  United States (1)

Top investigators

Steven G Simonson, MD (1)  ·  Xinyang Hu, PhD (1)

Results publications

PMID 20236457, PMID 21325598, PMID 23594433, PMID 24300013, PMID 24691607, PMID 25805204, PMID 26443879, PMID 26836806, PMID 28131429, PMID 30181084, PMID 30444173, PMID 30860564, PMID 31723612, PMID 33475735, PMID 9971864